Huang Wenqing, Jin Aihong, Zhang Jieting, Wang Chaoqun, Tsang Lai Ling, Cai Zhiming, Zhou Xiaping, Chen Hao, Chan Hsiao Chang
Epithelial Cell Biology Research Center, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, PR China.
Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, PR China.
Oncotarget. 2017 Mar 22;8(40):66951-66959. doi: 10.18632/oncotarget.16441. eCollection 2017 Sep 15.
Endometriotic tissues exhibit high migration ability with the underlying mechanisms remain elusive. Our previous studies have demonstrated that cystic fibrosis transmembrane conductance regulator (CFTR) acts as a tumor suppressor regulating cell migration. In the present study, we explored whether CFTR plays a role in the development of human endometriosis. We found that both mRNA and protein expression levels of CFTR and urokinase-type plasminogen activator receptor (uPAR) were significantly increased in ectopic endometrial tissues from patients with endometriosis compared to normal endometrial tissues from women without endometriosis and positively correlated. In human endometrial Ishikawa (ISK) cells, overexpression of CFTR stimulated cell migration with upregulated NFκB p65 and uPAR. Knockdown of CFTR inhibited cell migration. Furthermore, inhibition of NFκB with its inhibitors (curcumin or Bay) significantly reduced the expression of uPAR and cell migration in the CFTR-overexpressing ISK cells. Collectively, the present results suggest that the CFTR-NFκB-uPAR signaling may contribute to the progression of human endometriosis, and indicate potential targets for diagnosis and treatment.
子宫内膜异位组织具有高迁移能力,但其潜在机制仍不清楚。我们之前的研究表明,囊性纤维化跨膜传导调节因子(CFTR)作为一种肿瘤抑制因子调节细胞迁移。在本研究中,我们探讨了CFTR是否在人类子宫内膜异位症的发展中起作用。我们发现,与无子宫内膜异位症女性的正常子宫内膜组织相比,子宫内膜异位症患者异位子宫内膜组织中CFTR和尿激酶型纤溶酶原激活剂受体(uPAR)的mRNA和蛋白表达水平均显著升高,且呈正相关。在人子宫内膜Ishikawa(ISK)细胞中,CFTR的过表达通过上调NFκB p65和uPAR刺激细胞迁移。CFTR的敲低抑制细胞迁移。此外,用其抑制剂(姜黄素或Bay)抑制NFκB可显著降低CFTR过表达的ISK细胞中uPAR的表达和细胞迁移。总体而言,目前的结果表明CFTR-NFκB-uPAR信号通路可能促进人类子宫内膜异位症的进展,并指出了诊断和治疗的潜在靶点。